The Enterprise Value as of March 2026 (TTM) for Syndax Pharmaceuticals, Inc. (SNDX) is 2.28B

According to Syndax Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.28B. This represents a change of 75.87% compared to the average of 1.30B of the last 4 quarters.

Syndax Pharmaceuticals, Inc. (SNDX) Historical Enterprise Value (quarterly & annually)

How has SNDX Enterprise Value performed in the past?

The mean historical Enterprise Value of Syndax Pharmaceuticals, Inc. over the last ten years is 837.07M. The current 2.28B Enterprise Value has changed 27.19% with respect to the historical average. Over the past ten years (40 quarters), SNDX's Enterprise Value was at its highest in in the December 2025 quarter at 2.03B. The Enterprise Value was at its lowest in in the March 2016 quarter at 37.31M.

Syndax Pharmaceuticals, Inc. (SNDX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Syndax Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Syndax Pharmaceuticals, Inc. (SNDX) Average Enterprise Value

How has SNDX Enterprise Value performed in the past?

The current Enterprise Value of Syndax Pharmaceuticals, Inc. (SNDX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Syndax Pharmaceuticals, Inc. (SNDX) Enterprise Value vs. Peers

How is SNDX’s Enterprise Value compared to its peers?

Syndax Pharmaceuticals, Inc.’s Enterprise Value is greater than Relay Therapeutics, Inc. (1.80B), greater than Inhibrx Biosciences, Inc. (853.64M), greater than Amylyx Pharmaceuticals, Inc. (942.22M), greater than ORIC Pharmaceuticals, Inc. (1.16B), greater than Nektar Therapeutics (1.62B), greater than Sana Biotechnology, Inc. (903.66M), greater than Immatics N.V. (754.75M), greater than CureVac N.V. (537.96M), greater than Atai Beckley N.V (668.58M), greater than Zenas BioPharma, Inc. (892.50M),

Build a custom stock screener for Syndax Pharmaceuticals, Inc. (SNDX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Syndax Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Syndax Pharmaceuticals, Inc. (SNDX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Syndax Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.